Rowatinex - 45 Capsules

For the treatment of urolithiasis.

Tradename: Rowatinex

Rowatinex

* Compound: Each capsule contains:

α-pinene 24.8 mg

β-pinene 6.2 mg

camphene 15.0 mg

borneol 10.0 mg

anethol 4.0 mg

fenchon 4.0 mg

cineole 3.0 mg

* Auxiliary components:

olive oil

composition of the capsule shell: gelatin, glycerin 85%, sodium ethyl parahydroxybenzoate (E 215), sodium propyl parahydroxybenzoate (E 217), dyes sunset yellow (E 110) and quinoline yellow 70% (E 104).

* Properties: Rowatinex® promotes disintegration and elimination of stones from the kidneys and urinary tract. The inhibitory effect of Rowatinex® on the formation of kidney and urinary stones has been established in a number of animal studies. Rovatinex® has an antispasmodic effect, promotes the passage of stones through the urinary tract, reduces pain in renal and ureteral colic. Rowatinex® enhances renal blood flow and reduces inflammation.

Rowatinex® has antibacterial activity against a number of gram-positive and gram-negative microorganisms.

* Indications: - for the treatment of urolithiasis

Dosage and administration: inside.

Recommended dosing regimen:

Adults: 1-2 capsules 4 times a day 30 minutes before meals.

The duration of the course of treatment is set by the doctor individually, depending on the course of the disease.

* Contraindications: hypersensitivity to drug components

children and adolescents up to 18 years of age

* Precautionary measures: Rowatinex® is not recommended for use in patients with severe renal colic, anuria or severe urinary tract infection. During treatment, fluid intake should be increased.

The drug contains excipients ethyl parahydroxybenzoate, propyl parahydrocybenzoate, which can cause allergic reactions (possibly delayed).

Pregnancy and lactation

There are no data on the use of the drug during pregnancy in humans. There are no data on the teratogenicity of the drug in animals. However, at least some of the ingredients may cross the placenta. The drug is not recommended for use during pregnancy or breastfeeding.

Features of the influence of the drug on the ability to drive a vehicle or potentially dangerous mechanisms

There are no data on the effect of Rowatinex® capsules on these functions in patients.

* Side effects: A small number of patients noted mild and transient discomfort in the stomach. Vomiting has been very rare. In two cases, intolerance to the drug was noticed (the cause is unknown).

* Storage method: At a temperature not higher than 25 degrees.

* Package: The cardboard box contains 3 blisters of 15 capsules.